Essex Investment Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,473
Closed -$654K 537
2018
Q3
$654K Buy
11,473
+2,770
+32% +$173K 0.08% 273
2018
Q2
$695K Buy
+8,703
New +$722K 0.09% 268
2016
Q4
Sell
-12,860
Closed -$1.34M 378
2016
Q3
$1.34M Hold
12,860
0.22% 115
2016
Q2
$949K Buy
12,860
+3,735
+41% +$253K 0.16% 147
2016
Q1
$513K Hold
9,125
0.09% 221
2015
Q4
$616K Hold
9,125
0.1% 214
2015
Q3
$423K Buy
+9,125
New +$442K 0.07% 243

Other funds holding NVRO

Essex Investment Management's NVRO Position: Q4 2018 in Review

Essex Investment Management sold out of NEVRO CORP. (NVRO) in Q4 2018, closing a stake of 11,473 shares — an estimated $654K sold.

Essex Investment Management first reported a position in NVRO in Q3 2015 and held it in 7 quarters. The position peaked at $1.34M in Q3 2016. 157 funds tracked by Wall St. Rank hold NVRO as of Q4 2018.

  • Essex Investment Management reported no remaining NEVRO CORP. position as of Q4 2018 after selling out during the quarter.
  • Essex Investment Management sold 11,473 NEVRO CORP. shares in Q4 2018, an estimated $654K.
  • Essex Investment Management first reported a position in NEVRO CORP. in Q3 2015 and held it in 7 quarters.
  • Essex Investment Management's NEVRO CORP. position peaked at $1.34M in Q3 2016.
  • 157 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.